Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Thorpe

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Abdominal Radiology (New York)|May 5, 2023
Potential applications of PET/MRI in non-oncologic conditions within the abdomen and pelvisDavid J Bartlett, Hiroaki Takahashi, Corrie R Bach, et al.
AJR. American Journal of Roentgenology|May 19, 2021
Frequency and Characteristics of Nodal and Deltoid FDG and <sup>11</sup>C-Choline Uptake on PET Performed After COVID-19 VaccinationDane G Schroeder, Samuel Jang, Derek R Johnson, et al.
Clinical Genitourinary Cancer|February 26, 2021
Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predictors of Improved OSMohamed E Ahmed, Vidhu B Joshi, Mohamed Badawy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with <sup>131</sup>I-MIBGAri Kane, Matthew P Thorpe, Michael A Morse, et al.
Annals of Nuclear Medicine|September 17, 2024
Detection rate of gastrin-releasing peptide receptor (GRPr) targeted tracers for positron emission tomography (PET) imaging in primary prostate cancer: a systematic review and meta-analysisGokce Belge Bilgin, Cem Bilgin, Atakan Orscelik, et al.
Theranostics|April 22, 2024
Theranostics and artificial intelligence: new frontiers in personalized medicineGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
Medical Education|March 3, 2020
Awareness of implicit bias mitigates discrimination in radiology resident selectionCharles M Maxfield, Matthew P Thorpe, Terry S Desser, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|June 1, 2019
Bias in Radiology Resident Selection: Do We Discriminate Against the Obese and Unattractive?Charles M Maxfield, Matthew P Thorpe, Terry S Desser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 25, 2025
Outcomes of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and ParagangliomaGokce Belge Bilgin, Brian J Burkett, Cem Bilgin, et al.
Frontiers in Oncology|July 29, 2024
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer <sup>177</sup>Lu-PSMA-617 therapyGokce Belge Bilgin, Cem Bilgin, Daniel S Childs, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Abdominal Radiology (New York)|May 5, 2023
Potential applications of PET/MRI in non-oncologic conditions within the abdomen and pelvisDavid J Bartlett, Hiroaki Takahashi, Corrie R Bach, et al.
AJR. American Journal of Roentgenology|May 19, 2021
Frequency and Characteristics of Nodal and Deltoid FDG and <sup>11</sup>C-Choline Uptake on PET Performed After COVID-19 VaccinationDane G Schroeder, Samuel Jang, Derek R Johnson, et al.
Clinical Genitourinary Cancer|February 26, 2021
Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predictors of Improved OSMohamed E Ahmed, Vidhu B Joshi, Mohamed Badawy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with <sup>131</sup>I-MIBGAri Kane, Matthew P Thorpe, Michael A Morse, et al.
Annals of Nuclear Medicine|September 17, 2024
Detection rate of gastrin-releasing peptide receptor (GRPr) targeted tracers for positron emission tomography (PET) imaging in primary prostate cancer: a systematic review and meta-analysisGokce Belge Bilgin, Cem Bilgin, Atakan Orscelik, et al.
Theranostics|April 22, 2024
Theranostics and artificial intelligence: new frontiers in personalized medicineGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
Medical Education|March 3, 2020
Awareness of implicit bias mitigates discrimination in radiology resident selectionCharles M Maxfield, Matthew P Thorpe, Terry S Desser, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|June 1, 2019
Bias in Radiology Resident Selection: Do We Discriminate Against the Obese and Unattractive?Charles M Maxfield, Matthew P Thorpe, Terry S Desser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 25, 2025
Outcomes of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and ParagangliomaGokce Belge Bilgin, Brian J Burkett, Cem Bilgin, et al.
Frontiers in Oncology|July 29, 2024
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer <sup>177</sup>Lu-PSMA-617 therapyGokce Belge Bilgin, Cem Bilgin, Daniel S Childs, et al.
Pageof 4